Surviving Retirement
Followers
Thursday, 8 October 2015
Five things for pharma marketers to know: Tuesday, October 6
The FDA approves another generic version of Abilify; drug price increases driving profit growth; Spark plans to submit eye-drug to the FDA in 2016
from Most popular articles from Medical Marketing and Media http://ift.tt/1VFgqb0
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment